期刊文献+

防控HIV感染的新策略——使用抗逆转录病毒药物进行HIV-1感染的暴露前预防 被引量:3

原文传递
导出
摘要 HIV-1感染是目前全世界范围内最具挑战性的公共卫生难题.尽管联合抗逆转录病毒治疗(cART)显著改变了HIV-1感染的典型病程,极大地增加了HIV-1感染者的预期寿命,但如何有效地控制HIV-1的传播、减少新发感染者的数量并对特殊人群[如性工作者、发生男-男性行为者(men who have sex with men,MSM)人群等]实施有效干预仍是目前各个国家面临的共同问题.目前使用的预防HIV-1经性途径传播的策略包括安全套的推广使用、安全性行为的宣教等,并未有效地控制HIV-1在普通人群中的传播,在某些特殊人群(如非洲女性)甚至出现了发病率逐渐上升的趋势.
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第12期1067-1070,共4页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献26

  • 1Joint United Nations Programme on HIV/AIDS (UNAIDS).UNAIDS report on the global AIDS epidemic 2010[R/OL].(2010-11-23)[2011-04-26].http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf.
  • 2Liu AY,Grant RM,Buchbinder SP.Preexposure prophylaxis for HIV:unproven promise and potential pitfalls.JAMA,2006,296:863-865.
  • 3Buchbinder SP,Liu A.Pre-exposure prophylaxis and the promise of combination prevention approaches.AIDS Behav,2011,15Suppl 1:S72-79.
  • 4García-Lerma JG,Paxton L,Kilmarx PH,et al.Oral preexposure prophylaxis for HIV prevention.Trends Pharmacol Sci,2010,31:74-81.
  • 5Haase AT.Perils at mucosal front lines for HIV and SIV and their hosts.Nat Rev Immunol,2005,5:783-792.
  • 6Haase AT.Targeting early infection to prevent HIV-1 mucosal transmission.Nature,2010,464:217-223.
  • 7Li Q,Estes JD,Schlievert PM,et al.Glycerol monolaurate prevents mucosal SIV transmission.Nature,2009,458:1034-1038.
  • 8García-Lerma JG,Otten RA,Qari SH,et al.Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.PLoS Med,2008,5:e28.
  • 9Denton PW,Estes JD,Sun Z,et al.Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.PLoS Med,2008,5:e16.
  • 10Neff CP,Ndolo T,Tandon A,et al.Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.PLoS One,2010,5:el 5257.

同被引文献33

  • 1Bailey RC,Moses S,Parker CB,et al. Male circumcision forHIV prevention in young men in Kisumu, Kenya: a randomisedcontrolled trial[J]. Lancet, 2007, 369(9562) : 643 - 656.
  • 2Gray RH,Kigozi G, Serwadda D,et al. Male circumcision forHIV prevention in men in Rakai* Uganda: a randomised trial[J]. Lancet, 2007,369(9562) : 657 - 666.
  • 3Ramjee G,Govinden R, Morar NS,et al. South Africa's experi-ence of the closure of the cellulose sulphate microbicide trial [J].PLoS Med, 2007,4(7): e235.
  • 4Pitisuttithum P,Gilbert P, Gurwith M, et al. Randomized, doubleblind, placebo controlled efficacy trial of a bivalent recombinant glyco-protein 120 HIV-1 vaccine among injection drug users in Bangkok,Thailand [J]. J Infect Dis, 2006,194(12) : 1661 - 1671.
  • 5Anderson PL, Kiser JJ, Gardner EM, et al. Pharmacologicalconsiderations for tenofovir and emtricitabine to prevent HIV in-fection[J]. J Antimicrob Chemother,2011,66(2) :240 -250.
  • 6Centers for Disease Control and Prevention (CDC). Interim guid-ance: preexposure prophylaxis for the prevention of HIV infec-tion in men who have sex with men[J]. MMWR Morb MortalWkly Rep,2011,60(3) :65 -68.
  • 7Mimiaga MJ,case P,Johnson CV et al. Preexposure antiretro-viral prophylaxis attitudes in high - risk Boston area men whoreport having sex withmen ? limited knowledge and experiencebut potential for increased utilization after education [J]. J Ac-quir Immune Defic Syndr. 2009,;50(1) :77 - 83.
  • 8Barash EA, Golden M. Awareness and use of HIV pre - expo-sure prophylaxis among attendees of a Seattle gay pride eventand sexually transmitted disease clinic[ J J. AIDS Patient CareSTDS, 2010, 24(11):689-691.
  • 9Buchbinder SP,Liu A. Pre - exposure Prophylaxis and thePromise of Combination Prevention Approaches[J], AIDS Be-hav, 2011,15( Suppl 1):S72 -79.
  • 10Grant RM, Lama JR,Anderson PL, et al. Preexposure chemo-prophylaxis for HIV prevention in men who have sex with men, [J]. NEngl J Med, 2010,363(27) :2587~2599.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部